159 related articles for article (PubMed ID: 15205596)
1. The clinical development of new mitotic inhibitors that stabilize the microtubule.
Mani S; Macapinlac M; Goel S; Verdier-Pinard D; Fojo T; Rothenberg M; Colevas D
Anticancer Drugs; 2004 Jul; 15(6):553-8. PubMed ID: 15205596
[TBL] [Abstract][Full Text] [Related]
2. Suppression of microtubule dynamics by discodermolide by a novel mechanism is associated with mitotic arrest and inhibition of tumor cell proliferation.
Honore S; Kamath K; Braguer D; Wilson L; Briand C; Jordan MA
Mol Cancer Ther; 2003 Dec; 2(12):1303-11. PubMed ID: 14707271
[TBL] [Abstract][Full Text] [Related]
3. Strategies for the development of novel Taxol-like agents.
Mooberry SL
Methods Mol Med; 2007; 137():289-302. PubMed ID: 18085237
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and biological assessment of simplified analogues of the potent microtubule stabilizer (+)-discodermolide.
Mínguez JM; Kim SY; Giuliano KA; Balachandran R; Madiraju C; Day BW; Curran DP
Bioorg Med Chem; 2003 Jul; 11(15):3335-57. PubMed ID: 12837544
[TBL] [Abstract][Full Text] [Related]
5. Taxol and discodermolide represent a synergistic drug combination in human carcinoma cell lines.
Martello LA; McDaid HM; Regl DL; Yang CP; Meng D; Pettus TR; Kaufman MD; Arimoto H; Danishefsky SJ; Smith AB; Horwitz SB
Clin Cancer Res; 2000 May; 6(5):1978-87. PubMed ID: 10815923
[TBL] [Abstract][Full Text] [Related]
6. Synthetic analogues of the microtubule-stabilizing agent (+)-discodermolide: preparation and biological activity.
Gunasekera SP; Mickel SJ; Daeffler R; Niederer D; Wright AE; Linley P; Pitts T
J Nat Prod; 2004 May; 67(5):749-56. PubMed ID: 15165132
[TBL] [Abstract][Full Text] [Related]
7. Insights into the interaction of discodermolide and docetaxel with tubulin. Mapping the binding sites of microtubule-stabilizing agents by using an integrated NMR and computational approach.
Canales A; Rodríguez-Salarichs J; Trigili C; Nieto L; Coderch C; Andreu JM; Paterson I; Jiménez-Barbero J; Díaz JF
ACS Chem Biol; 2011 Aug; 6(8):789-99. PubMed ID: 21539341
[TBL] [Abstract][Full Text] [Related]
8. Synergistic suppression of microtubule dynamics by discodermolide and paclitaxel in non-small cell lung carcinoma cells.
Honore S; Kamath K; Braguer D; Horwitz SB; Wilson L; Briand C; Jordan MA
Cancer Res; 2004 Jul; 64(14):4957-64. PubMed ID: 15256469
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis, and evaluation of carbamate-substituted analogues of (+)-discodermolide.
Smith AB; Freeze BS; Lamarche MJ; Hirose T; Brouard I; Rucker PV; Xian M; Sundermann KF; Shaw SJ; Burlingame MA; Horwitz SB; Myles DC
Org Lett; 2005 Jan; 7(2):311-4. PubMed ID: 15646985
[TBL] [Abstract][Full Text] [Related]
10. Differential effects of natural product microtubule stabilizers on microtubule assembly: single agent and combination studies with taxol, epothilone B, and discodermolide.
Gertsch J; Meier S; Müller M; Altmann KH
Chembiochem; 2009 Jan; 10(1):166-75. PubMed ID: 19058273
[TBL] [Abstract][Full Text] [Related]
11. Distinct pose of discodermolide in taxol binding pocket drives a complementary mode of microtubule stabilization.
Khrapunovich-Baine M; Menon V; Verdier-Pinard P; Smith AB; Angeletti RH; Fiser A; Horwitz SB; Xiao H
Biochemistry; 2009 Dec; 48(49):11664-77. PubMed ID: 19863156
[TBL] [Abstract][Full Text] [Related]
12. Differential mitotic responses to microtubule-stabilizing and -destabilizing drugs.
Chen JG; Horwitz SB
Cancer Res; 2002 Apr; 62(7):1935-8. PubMed ID: 11929805
[TBL] [Abstract][Full Text] [Related]
13. A quantitative evaluation of the effects of inhibitors of tubulin assembly on polymerization induced by discodermolide, epothilone B, and paclitaxel.
Dabydeen DA; Florence GJ; Paterson I; Hamel E
Cancer Chemother Pharmacol; 2004 May; 53(5):397-403. PubMed ID: 15060743
[TBL] [Abstract][Full Text] [Related]
14. Discodermolide analogues as the chemical component of combination bacteriolytic therapy.
Smith AB; Freeze BS; LaMarche MJ; Sager J; Kinzler KW; Vogelstein B
Bioorg Med Chem Lett; 2005 Aug; 15(15):3623-6. PubMed ID: 15979874
[TBL] [Abstract][Full Text] [Related]
15. Total synthesis of the potent microtubule-stabilizing agent (+)-discodermolide.
Harried SS; Lee CP; Yang G; Lee TI; Myles DC
J Org Chem; 2003 Aug; 68(17):6646-60. PubMed ID: 12919029
[TBL] [Abstract][Full Text] [Related]
16. (+)-Discodermolide binds to microtubules in stoichiometric ratio to tubulin dimers, blocks taxol binding and results in mitotic arrest.
Hung DT; Chen J; Schreiber SL
Chem Biol; 1996 Apr; 3(4):287-93. PubMed ID: 8807856
[TBL] [Abstract][Full Text] [Related]
17. Toward understanding how the lactone moiety of discodermolide affects activity.
Shaw SJ; Sundermann KF; Burlingame MA; Myles DC; Freeze BS; Xian M; Brouard I; Smith AB
J Am Chem Soc; 2005 May; 127(18):6532-3. PubMed ID: 15869264
[TBL] [Abstract][Full Text] [Related]
18. A common pharmacophore for cytotoxic natural products that stabilize microtubules.
Ojima I; Chakravarty S; Inoue T; Lin S; He L; Horwitz SB; Kuduk SD; Danishefsky SJ
Proc Natl Acad Sci U S A; 1999 Apr; 96(8):4256-61. PubMed ID: 10200249
[TBL] [Abstract][Full Text] [Related]
19. Both microtubule-stabilizing and microtubule-destabilizing drugs inhibit hypoxia-inducible factor-1alpha accumulation and activity by disrupting microtubule function.
Escuin D; Kline ER; Giannakakou P
Cancer Res; 2005 Oct; 65(19):9021-8. PubMed ID: 16204076
[TBL] [Abstract][Full Text] [Related]
20. A photoaffinity analogue of discodermolide specifically labels a peptide in beta-tubulin.
Xia S; Kenesky CS; Rucker PV; Smith AB; Orr GA; Horwitz SB
Biochemistry; 2006 Oct; 45(39):11762-75. PubMed ID: 17002277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
